These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 14975519

  • 1. Serum markers of stored body iron are not appropriate markers of health effects of iron: a focus on serum ferritin.
    Lee DH, Jacobs DR.
    Med Hypotheses; 2004; 62(3):442-5. PubMed ID: 14975519
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes.
    Lee DH, Zacharski LR, Jacobs DR.
    Am Heart J; 2006 Jun; 151(6):1247.e1-7. PubMed ID: 16781229
    [Abstract] [Full Text] [Related]

  • 3. Body iron stores and coronary atherosclerosis assessed by coronary angiography.
    Auer J, Rammer M, Berent R, Weber T, Lassnig E, Eber B.
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):285-90. PubMed ID: 12616808
    [Abstract] [Full Text] [Related]

  • 4. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).
    Hilken A, Langebrake C, Wolschke C, Kersten JF, Rohde H, Nielsen P, Kröger N.
    Ann Hematol; 2017 Aug; 96(8):1379-1388. PubMed ID: 28585071
    [Abstract] [Full Text] [Related]

  • 5. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB, Cappellini MD, Kattamis A, Viprakasit V, Musallam KM, Zhu Z, Taher AT.
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [Abstract] [Full Text] [Related]

  • 6. Iron metabolism in kidney allograft recipients: still a mystery?
    Malyszko J, Głowińska I, Malyszko JS, Levin-Iaina N, Koc-Zorawska E, Mysliwiec M.
    Transplant Proc; 2011 Oct; 43(8):2973-5. PubMed ID: 21996204
    [Abstract] [Full Text] [Related]

  • 7. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
    Yeap BB, Divitini ML, Gunton JE, Olynyk JK, Beilby JP, McQuillan B, Hung J, Knuiman MW.
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analytical evaluation of serum non-transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population.
    Sugiura T, Dohi Y, Takase H, Fujii S, Seo Y, Ohte N.
    Medicine (Baltimore); 2021 Feb 19; 100(7):e24722. PubMed ID: 33607814
    [Abstract] [Full Text] [Related]

  • 10. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD.
    Am J Hematol; 2009 Jan 19; 84(1):29-33. PubMed ID: 19006228
    [Abstract] [Full Text] [Related]

  • 11. The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress.
    Olcay L, Serteser M, Kolay M, Balci HF, Yildirim ÜM, Tekgündüz SA, Hazirolan T, Terzi YK.
    J Pediatr Hematol Oncol; 2017 Aug 19; 39(6):425-439. PubMed ID: 28731917
    [Abstract] [Full Text] [Related]

  • 12. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E, Ryan JD, Russell J, Coughlan B, Tjalsma H, Swinkels DW, Stewart S, Crowe JP.
    Acta Haematol; 2015 Aug 19; 133(2):155-61. PubMed ID: 25277871
    [Abstract] [Full Text] [Related]

  • 13. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G.
    Am J Gastroenterol; 2001 Aug 19; 96(8):2448-55. PubMed ID: 11513189
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iron hypothesis and coronary artery disease in geriatric patients.
    Mokhtari H, Bagheri B, Rasouli M.
    Arch Physiol Biochem; 2020 Feb 19; 126(1):17-22. PubMed ID: 30032657
    [Abstract] [Full Text] [Related]

  • 17. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    N Engl J Med; 2005 Apr 28; 352(17):1769-78. PubMed ID: 15858186
    [Abstract] [Full Text] [Related]

  • 18. Can iron chelators influence the progression of atherosclerosis?
    Marx JJ, Kartikasari AE, Georgiou NA.
    Hemoglobin; 2008 Apr 28; 32(1-2):123-34. PubMed ID: 18274990
    [Abstract] [Full Text] [Related]

  • 19. Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment.
    Porter JB, El-Alfy M, Viprakasit V, Giraudier S, Chan LL, Lai Y, El-Ali A, Han J, Cappellini MD.
    Eur J Haematol; 2016 Jan 28; 96(1):19-26. PubMed ID: 25691036
    [Abstract] [Full Text] [Related]

  • 20. Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B(12) treatment.
    Gafter-Gvili A, Prokocimer M, Breuer W, Cabantchik IZ, Hershko C.
    Hematol J; 2004 Jan 28; 5(1):32-4. PubMed ID: 14745427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.